ViAqua Therapeutics addresses the critical need for effective and affordable health management solutions in the aquaculture industry. Their primary innovation is a novel oral delivery platform designed to deliver RNA, aiming to induce resistance to diseases like White Spot Shrimp Virus. This technology was co-developed with Skretting, a Nutreco company.